IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 72 filers reported holding IMMUNE DESIGN CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $12,604,000 | +55.8% | 3,231,753 | +313.4% | 0.01% | +50.0% |
| Q3 2017 | $8,091,000 | +9.2% | 781,753 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $7,412,000 | +47.2% | 760,253 | +2.7% | 0.00% | +33.3% |
| Q1 2017 | $5,034,000 | +23.7% | 740,253 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $4,071,000 | -33.9% | 740,253 | -8.9% | 0.00% | -33.3% |
| Q3 2016 | $6,157,000 | -7.1% | 812,226 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $6,628,000 | -37.2% | 812,226 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $10,559,000 | -35.3% | 812,226 | 0.0% | 0.01% | -25.0% |
| Q4 2015 | $16,309,000 | +59.8% | 812,226 | -2.9% | 0.01% | +60.0% |
| Q3 2015 | $10,204,000 | -40.9% | 836,426 | 0.0% | 0.01% | -37.5% |
| Q2 2015 | $17,272,000 | +9.1% | 836,426 | +11.6% | 0.01% | +14.3% |
| Q1 2015 | $15,827,000 | -30.3% | 749,726 | +1.6% | 0.01% | -30.0% |
| Q4 2014 | $22,716,000 | +60.4% | 738,026 | -8.0% | 0.01% | +66.7% |
| Q3 2014 | $14,163,000 | – | 802,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $4,080,000 | 4.69% |
| Versant Venture Management, LLC | 2,208,210 | $7,287,093,000 | 2.33% |
| EcoR1 Capital, LLC | 4,437,600 | $14,422,000 | 1.45% |
| BVF INC/IL | 4,106,200 | $13,550,000 | 1.37% |
| Abingworth LLP | 352,300 | $1,145,000 | 0.71% |
| DAFNA Capital Management LLC | 328,500 | $1,084,000 | 0.53% |
| Bain Capital Public Equity Management, LLC | 1,680,987 | $5,547,000 | 0.40% |
| Telemetry Investments, L.L.C. | 248,800 | $821,000 | 0.31% |
| Stonepine Capital Management, LLC | 161,226 | $532,000 | 0.28% |
| Focused Wealth Management, Inc | 12,395 | $41,000 | 0.01% |